Dienogest vs. Laparoscopic Cystectomy for Ovarian Endometrioma in Females Attending Outpatient Clinic in Suez Canal University Hospital
Not Applicable
Not yet recruiting
- Conditions
- Fertility-female
- Registration Number
- PACTR202010622528145
- Lead Sponsor
- suez canal university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
Unilateral endometrioma
? Size 3-8 cm
? Age 18-45 years
? Regular cycles
? No previous ovarian operations in the last 3 months
Exclusion Criteria
Amenorrhea for 2 or more years
? Suspected or confirmed malignancy
? Women within 2 years of menarche
? Women on progesterone or combined estrogen and progestin contraception
? Menopause
? Pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Dienogest's efficacy in treating ovarian endometrioma compared to laparoscopic cystectomy?
How does Dienogest compare to standard-of-care treatments like GnRH agonists in preserving ovarian reserve for fertility preservation?
Are there specific biomarkers that predict response to Dienogest over surgical intervention in endometrioma patients?
What are the potential adverse events associated with long-term Dienogest use in reproductive-age women?
What combination therapies involving Dienogest are being explored for endometriosis-related infertility in clinical research?